HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis

Clinical Cancer Research

Volumn 18, Issue 5, 2012, Pages 1246-1256

  Pan, Bing ^a   Ren, Hui ^a   He, Yubin ^b   Lv, Xiaofeng ^b   Ma, Yijing ^a   Li, Jing ^c   Huang, Li ^c   Yu, Baoqi ^a   Kong, Jian ^d   Niu, Chenguang ^a   Zhang, Youyi ^a   Sun, Wen Bing ^d   Zheng, Lemin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INTEGRIN; PROTEIN KINASE C;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST METASTASIS; CANCER GROWTH; CANCER LOCALIZATION; CELL ADHESION; CELL ASSAY; CELL STRAIN MCF 7; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METASTASIS; LUNG METASTASIS; MALE; MOLECULAR PATHOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; TUMOR PROMOTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ADULT; AGED; ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR MATRIX; FEMALE; GLYCOSYLATION; HUMANS; INTEGRINS; LIPOPROTEINS, HDL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM METASTASIS; OXIDATION-REDUCTION; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84863229490     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-0817     Document Type: Article

References (50)

1. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. CA Cancer J Clin 2010;60:207-21.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66. (Pubitemid 46148091)
3. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29.
4. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008;300:2754-64.
5. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 2008;109:389-95. (Pubitemid 351644852)
6. Wittekind C, Neid M. Cancer invasion and metastasis. Oncology 2005;69 Suppl 1:14-6. (Pubitemid 41433536)
7. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell 2006;127:679-95. (Pubitemid 44781029)
8. Lee YB, Ko KC, Shi MD, Liao YC, Chiang TA, Wu PF, et al. Alpha-Mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells. J Food Sci 2010;75:H13-23.
9. Geng JG. Interaction of vascular endothelial cells with leukocytes, platelets and cancer cells in inflammation, thrombosis and cancer growth and metastasis. Acta Pharmacol Sin 2003;24:1297-300.
10. Nizamutdinova IT, Lee GW, Lee JS, Cho MK, Son KH, Jeon SJ, et al. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 2008;29:1885-92.
11. Hynes RO, Lander AD. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell 1992;68:303-22.
12. Rathinam R, Alahari SK. Alahari important role of integrins in the cancer biology. Cancer Metastasis Rev 2010;29:223-37.
13. Cohen MB, Griebling TL, Ahaghotu CA, Rokhlin OW, Ross JS. Cellular adhesion molecules in urologic malignancies. Am J Clin Pathol 1997;107:56-63. (Pubitemid 27104637)
14. Ng T, Shima D, Squire A, Bastiaens PI, Gschmeissner S, Humphries MJ, et al. PKC alpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J 1999;18:3909-23. (Pubitemid 29335844)
15. Parsons M, Keppler MD, Kline A, Messent A, Humphries MJ, Gilchrist R, et al. Site-directed perturbation of protein kinase C- integrin interaction blocks carcinoma cell chemotaxis. Mol Cell Biol 2002;22:5897-911. (Pubitemid 34815838)
16. Kolanus W, Seed B. Integrins and inside-out signal transduction: Converging signals from PKC and PIP3. Curr Opin Cell Biol 1997;9:725-31. (Pubitemid 27424930)
17. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707-14. (Pubitemid 8110784)
18. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 1980;46:649-54. (Pubitemid 10009820)
19. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15. (Pubitemid 19043669)
20. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, et al. HDLcholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-10. (Pubitemid 47481452)
21. Jafri H, Alsheikh-Ali AA, Karas RH. Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. J Am Coll Cardiol 2010;55:2846-54.
22. Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, et al. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev 1998;7:483-8. (Pubitemid 28354111)
23. Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol 2008;18:671-7.
24. Furberg AS, Veierød MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004;96:1152-60. (Pubitemid 39207051)
25. Kontush A, Chapman MJ. Why is HDL functionally deficient in type 2 diabetes? Curr Diab Rep 2008;8:51-9. (Pubitemid 351384876)
26. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004;114:529-41. (Pubitemid 39572103)
27. Feng H, Li XA. Dysfunctional high-density lipoprotein. Curr Opin Endocrinol Diabetes Obes 2009;16:156-62.
28. Lapolla A, Brioschi M, Banfi C, Tremoli E, Bonfante L, Cristoni S, et al. On the search for glycated lipoprotein ApoA-I in the plasma of diabetic and nephropathic patients. J Mass Spectrom 2008;43:74-81. (Pubitemid 351251975)
29. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
30. Chung BH, Wilkinson T, Geer JC, Segrest JP. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 1980;21:284-91. (Pubitemid 10055505)
31. Hedrick CC, Thorpe SR, Fu MX, Harper CM, Yoo J, Kim SM, et al. Glycation impairs high-density lipoprotein function. Diabetologia 2000;43:312-20. (Pubitemid 30163474)
32. Valiyaveettil M, Kar N, Ashraf MZ, Byzova TV, Febbraio M, Podrez EA. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 2008;111:1962-71. (Pubitemid 351451506)
33. Gamble JR, Vadas MA. A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells. J Immunol Methods 1988;109:175-84.
34. Ratheesh A, Ingle A, Gude RP. Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biol Ther 2007;6:1743-52. (Pubitemid 351590309)
35. Kimura T, Tomura H, Mogi C, Kuwabara A, Ishiwara M, Shibasawa K, et al. Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal 2006;18:841-50. (Pubitemid 43208937)
36. Pan B, Ren H, Ma Y, Liu D, Yu B, Ji L, et al. HDL of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells. Int J Cancer 2011 Jul 29 [Epub ahead of print].
37. Rubinek IWT Diabetes mellitus and breast cancer. In. Masur K, Thévenod F, Zänker KS (eds): Diabetes and cancer. Epidemiological evidence and molecular links. Front diabetes. Basel, Karger: Plenum Press; 2008;19:97-113.
38. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
39. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6. (Pubitemid 39329586)
40. Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 1999;17:343-59. (Pubitemid 30135902)
41. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005;5:796-806. (Pubitemid 41400779)
42. Hoffman RM, Yang M. Color-coded fluorescence imaging of tumorhost interactions. Nat Protoc 2006;1:928-35.
43. Rotheneder M, Kostner GM. Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines. Int J Cancer 1989;43:875-9. (Pubitemid 19138197)
44. Martinez LO, Jacquet S, Tercé F, Collet X, Perret B, Barbaras R. New insight on the molecular mechanisms of high-density lipoprotein cellular interactions. Cell Mol Life Sci 2004;61:2343-60. (Pubitemid 39382026)
45. Kimura T, Tomura H, Mogi C, Kuwabara A, Damirin A, Ishizuka T, et al. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem 2006;281:37457-67. (Pubitemid 46042049)
46. Sekine Y, Demosky SJ, Stonik JA, Furuya Y, Koike H, Suzuki K, et al. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Mol Cancer Res 2010;8:1284-94.
47. Matsunaga T, Nakajima T, Miyazaki T, Koyama I, Hokari S, Inoue I, et al. Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cells. Metabolism 2003;52:42-9.
48. Norata GD, Pirillo A, Catapano AL. Modified HDL: biological and physiopathological consequences. Nutr Metab Cardiovasc Dis 2006;16:371-86. (Pubitemid 43994438)
49. Furberg AS, Espetvedt S, Emaus A, Khan N, Thune I. Low high-density lipoprotein cholesterol may signal breast cancer risk: recent findings and new hypotheses. Biomark Med 2007;1:121-31.
50. Kumar K, Sachdanandam P, Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem Int 1991;23:581-9.